Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
1. Elutia will exhibit EluPro™ at Vizient's technology exchange in September. 2. EluPro is the first FDA-cleared antibiotic-eluting bioenvelope for cardiac devices. 3. Product aims to improve patient safety and reduce post-surgical complications. 4. Technological innovation presented may enhance Elutia's market visibility and sales. 5. Vizient exchange attracts healthcare leaders, boosting potential industry connections.